ITRM
Iterum Therapeutics PLC
NASDAQ: ITRM · HEALTHCARE · BIOTECHNOLOGY
$0.03
+0.00% today
Updated 2026-04-29
Market cap
$3.75M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $1
Volume
32.7M
Iterum Therapeutics PLC (ITRM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11.30M | $-30.60M | $-75.89M | $-81.92M | $-54.53M | $-15.84M | $-18.47M | $-39.33M | $-26.77M |
| Capital expenditures | $812000.00 | $812000.00 | $90000.00 | $24000.00 | $11000.00 | $61000.00 | $62000.00 | $13000.00 | $2000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $348000.00 | $392000.00 | $1.29M | $2.17M | $2.76M | $4.32M | $22.11M | $784000.00 | $363000.00 |
| Free cash flow | $-12.11M | $-31.42M | $-75.98M | $-81.95M | $-54.54M | $-15.90M | $-18.54M | $-39.34M | $-26.77M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $36.29M | $-39.76M | $9.94M | — | — | — | — |